Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics

Booster doses of COVID-19 vaccines were recommended for people aged 18 years or older in November 2021 following the recommendation of an additional primary dose of COVID-19 vaccine for select immunocompromised populations on August 13, 2021.1 As of February 26, 2022, more than 93 million booster doses of COVID-19 vaccines had […]

Read More

Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations

The COVID-19 mRNA vaccines’ 2-dose primary series appeared to provide less protection against hospitalization from Omicron variant infections than Alpha and Delta infections, according to a recent study. A booster dose, however, was associated with increased effectiveness against Omicron hospitalizations at the same high levels achieved against earlier variants with 2 […]

Read More

COVID-19 Booster Shot Data Now Available From Nursing Homes

The Centers for Medicare & Medicaid Services (CMS) now provides data on COVID-19 vaccine booster shots among residents and staff at nursing homes. The data, which feature both completed vaccination and booster rates for individual facilities, is accessible via the Care Compare website. State and national averages of completed vaccination […]

Read More

FDA to Consider Future of COVID Booster Doses

The FDA today announced its vaccines advisory committee will meet April 6 to discuss the future of COVID-19 booster doses and how to tell if a specific strain of the coronavirus needs its own vaccine. The independent experts on the Vaccines and Related Biological Products Advisory Committee will be joined by representatives […]

Read More

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022

Summary What is already known about this topic? Adults aged ≥18 years reported adverse reactions less frequently after receipt of a homologous Pfizer-BioNTech COVID-19 booster dose than after the second primary dose. What is added by this report? Among persons aged 12–17 years, reactions after Pfizer-BioNTech booster vaccination were generally […]

Read More

Moderna Makes Case for Fourth COVID Vaccine Booster This Year, Shares Jump

Moderna Inc executives said on Thursday they believe a fourth COVID-19 vaccine shot will be needed late this year due to waning protection from earlier doses, which could push up sales in the second half of 2022. Chief Executive Stephane Bancel stressed that the company’s current sales projections for its […]

Read More

CDC: Time Blunts COVID-19 Booster Shot Protection Too

Protection against COVID-19 waned 4 to 5 months after a third dose of Pfizer (Comirnaty) or Moderna’s (Spikevax) vaccine, with steeply declining protection against emergency department (ED) visits as well as hospitalization during Omicron, researchers found. During the Omicron period, vaccine effectiveness (VE) against ED or urgent care visits was […]

Read More
Translate »